Aims To investigate depolarization and repolarization durations in people with Type 1 diabetes, including the relationship to age.
Introduction
Cardiovascular disease is the leading co-morbidity in diabetes [1] , which may lead to sudden cardiac death [2] . The dead in bed syndrome describes the sudden and unexpected nocturnal death of young people (<40 years of age, often men) with Type 1 diabetes and normal autopsies [3] .
One leading theory explaining the cause of the dead in bed syndrome is the presence of prolonged repolarization leading to fatal ventricular arrhythmias [3] , although the mechanism is largely unexplored. It has been speculated that the JT interval might be more specific as a marker of repolarization than the QT interval, which is a composite measure of depolarization and repolarization [4, 5] . Recent studies have investigated the JT interval against the QT interval in the general population [6, 7] and found that they predict mortality equally well in people with normal QRS duration (<120 ms), but that the JT interval is more suitable to use for people with bundle branch block (QRS duration >120 ms) [7] .
Although cardiovascular disease is the most common cause of death for people with Type 1 diabetes, cardiovascular screening in the diabetes clinic is mainly limited to blood pressure and the electrocardiogram (ECG). The ECG therefore plays a major role in cardiovascular risk assessment in the out-patient clinic.
It has previously been reported that people with Type 1 diabetes have an altered ECG [8] [9] [10] , but it is difficult to determine what can be attributed to complications resulting from Type 1 diabetes, or that are actually a direct cause of the disease. Consequently, little is known about the ECG characteristics for people with Type 1 diabetes without known heart disease.
The current study aimed to investigate differences in depolarization and repolarization in people with Type 1 diabetes without known heart disease. We hypothesized that repolarization duration might be increased, particularly in young people with Type 1 diabetes.
Participants and methods

Type 1 diabetes population
The Thousand & 1 Study is a cohort study of people with type 1 diabetes without known heart disease, conducted between 2010-2012 at the Steno Diabetes Center, Copenhagen. The population has been described in detail previously [11] [12] [13] . The study was approved by the Regional Ethics Committee (H-3-2009-139) and the Danish Data Protection Agency (00934-Geh-2010-003). Briefly, 1093 people without any known heart failure, coronary heart disease including stable angina, previous acute myocardial infarction, previous percutaneous coronary intervention, or coronary artery bypass, congenital heart disease, electrical conduction abnormalities including atrial fibrillation, atrial flutter, or left bundle branch block, pacemaker, or implantable cardioverter defibrillator (ICD), were included. All the participants were examined with ECG and echocardiography. In the current study, participants with an electronic ECG on file and ejection fraction >50% were included, 855 people in total.
Control population
To function as the control group without diabetes mellitus, participants were included from the Danish General Suburban Population Study (GESUS), which included participants between 2010-2013 aged 20 years or older [14, 15] ; 8823 participants had a digital ECG on file. Cases and controls were matched by age and gender, and two controls were matched for each case. The exclusion criteria for sampling to the control group were known diabetes mellitus and other clinical characteristics (similar to the Type 1 diabetes group): self-reported previous myocardial infarction, stable angina, ischemic heart disease, and pacemaker. In addition, participants with left bundle branch block, atrial fibrillation, and atrial flutter on the ECG, were also excluded, leaving 7644 participants (87%) available for enrolment. The MatchIt in R package [16] was used to ensure that participants were matched exactly by gender and optimally by age.
Measurements
Blood pressure for both groups was taken after five minutes of rest. The eGFR was calculated for both groups using the CKD-EPI formula [17] . For the control group, blood samples were taken on the day of the visit; for the other group, blood results were obtained from electronic patient records from previous visits closest to their enrolment in the study, which was set at a limit of 4 months. Creatinine was measured by an enzymatic method on a Hitachi 912 (Roche Diagnostics, Mannheim, Germany) and total cholesterol on a Vitros 5600 (Ortho Clinical Diagnostics, Illkirch-Graffenstaden, France) in the Type 1 diabetes group, and both biomarkers were measured using an enzymatic colorimetric method on a Cobas-6000 (Roche, Basel, Switzerland) in the control group. HbA 1c levels were measured on the Variant (BioRad Laboratories, CA, USA) for the Type 1 diabetes group and on a G8 HPLC analyzer (TOSOH, CA, USA). BMI was calculated as body weight per height squared (kg/m 2 ). Participants were categorised by smoking status (never, previous, current) and alcohol consumption (low, moderate and high) based on completed questionnaires. Low alcohol consumption was defined as less than 7 Danish units/week (84 g); moderate consumption was defined as 7-21 units/ week (84-252 g), and high consumption was defined at >21 units per week (252 g).
In the Type 1 diabetes group only, albuminuria was measured in morning spot urine samples using immunoassay. People with an albumin/creatinine ratio <3.4 mg/mmol creatinine were categorized as having normoalbuminuria. People with elevated levels (>3.4 mg/mmol) were subjected to 24-hour sterile urine collections, and they were categorised as part of the microalbuminuria group if two of three consecutive measurements were between 30-300 mg/day, or
What's new?
• This is the largest matched analysis of electrocardiographic changes in people with Type 1 diabetes without known heart disease and with normal ejection fraction.
• Depolarization duration is increased in people with Type 1 diabetes; repolarization duration is only increased in young people with Type 1 diabetes.
• Increased repolarization duration in young people suggests that they may be more prone to ventricular arrhythmias, potentially explaining the dead in bed syndrome and the increased risk of sudden cardiac death.
• Increased resting heart rate is present in people with Type 1 diabetes even without clinical heart disease.
part of the macroalbuminuria group if the result was >300 mg/day.
Electrocardiogram (ECG)
Resting 12-lead digital 10-second ECGs were recorded in both groups in the supine position after at least five minutes of rest. Automatic measurements of heart rate, QRS duration, JT interval, and QT interval were obtained using Marquette 12SL software (v. 2.41, GE Healthcare, Milwaukee, WI, USA). Heart rate corrected intervals were obtained using a linear correction [18, 19] . The linear regression model for heart rate-dependence was:
where I is an interval measurement in milliseconds, b is the intercept, a is the scaling constant (i.e. the heart ratedependence), RR is the average R-to-R interval in milliseconds, and e is the residual error. The heart rate corrected intervals, I c , were obtained for an expected heart rate of 60 bpm by using:
With this method, heart rate-corrected QT intervals (QT c ), QRS durations (QRS c ) and JT intervals (JT c ) were obtained, independent of heart rate (measured by the average R-to-R interval).
Statistics
Statistics were performed with R version 3.4.3. Continuous variables were reported as mean AE SD and categorical variables as %(n). For categorical values, the v 2 test was used to calculate differences in proportions. For continuous variables, Student's t-test was used to calculate mean differences. The least detectable mean differences were estimated for heart rate, QRS c duration, JT c interval and QT interval, with a power of 0.8 at the 0.05 significance level for sample sizes; SD was estimated at 17 ms for the JT c interval [19] , 16 ms for the QT c interval [19] , 14 ms for QRS c duration [7] , and 12 bpm for heart rate [7] . The least detectable mean differences were 1.4 bpm for heart rate, 1.6 ms for QRS c duration, 2.0 ms for the JT c interval, and 1.9 ms for the QT c interval.
Linear-regression models were used to examine the relationship of ECG variables to explanatory variables. Regression lines were deemed different in slope if the interaction term was significant, which was preferable to examining groups separately [20] . Predicted differences in intervals as a function of age were determined using regression models adjusted for sex, BMI, eGFR, systolic blood pressure, total cholesterol, alcohol consumption, and smoking status. The second order age term was included in the prediction if it was statistically significant and Akaike's An Information Criterion (AIC) also decreased. Missing observations were not imputed. P< 0.05 was considered significant.
Results
Demographics and clinical descriptions
In Table 1 , the clinical characteristics of people with Type 1 diabetes are compared to those of their age-and gender-matched controls. People with Type 1 diabetes had a lower BMI, lower blood pressure, and lower total cholesterol. Renal impairment was more common in people with Type 1 DM and HbA 1c levels were higher compared to controls. Smoking status was not different between the groups, but people with Type 1 diabetes consumed more alcohol compared to controls.
Heart rate
Electrocardiographic measurements were significantly different in people with Type 1 DM compared to controls ( Table 2 ). Type 1 diabetes was associated with an increased resting heart rate (RHR) of~10 bpm. RHR for men in the control group was 62AE11 bpm vs. 71AE13 bpm for men with Type 1 DM. RHR for women in the control group was 65AE11 bpm vs. 74AE12 bpm for women with Type 1 diabetes. There was no interaction between sex and diabetes for RHR (p=0.6). In people with and without Type 1 diabetes, heart rate increased with increasing levels of HbA 1c . The analysis is presented in the supporting information for this article ( Figure S4 ).
Interval measurements
The QT c increased on average by 3 ms in people with Type 1 DM compared to controls (Table 2) . Women had a longer QT c irrespective of diabetes status (men with Type 1 diabetes: 411AE16 ms, men in the control men group: 408AE19 ms, women with Type 1 diabetes: 416AE16 ms, women in the control group: 414AE19 ms, P=0.4 for interaction).
No difference was found in the JT c interval between the two groups (317AE17 vs. 316AE21, P=0.2) and there was no interaction between sex and diabetes (P=0.10).
People with Type 1 diabetes had an increased QRS c compared to controls. The QRS c was 100.2AE11.0 ms for men in the control group and 101.4AE10.8 ms for men with Type 1 diabetes. For women, the QRS c was 90.2AE9.4 ms in the control group compared to 92.6AE8.2 ms for women with Type 1 diabetes. There was no interaction between sex and diabetes (P=0.2).
ECG findings were consistent overall when adjusted for age, sex, BMI, systolic blood pressure, eGFR, total cholesterol, smoking, and alcohol consumption in a multivariate model (Table 3) . QRS c , JT c, and QT c did not depend on the HbA 1c level in people with Type 1 diabetes.
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Age dependencies of ECG intervals
The relationship between QT c and age is shown in Figures 1  and S1 . There was a significant interaction between age and diabetes for QT c (P<0.004). The relative difference between the groups was assessed with adjustment for sex, BMI, eGFR, systolic blood pressure, total cholesterol, smoking status, and alcohol consumption in the regression model ( Figure 1 ). Compared to controls, QT c increased relatively in younger people with Type 1 diabetes, and QT c increased with age in both Type 1 diabetes and controls. The maximal predicted QT c difference was 13.8 ms (95% CI: 8.6-19.0 ms, P<0.001) at 20 years of age; at 30 years of age the difference was 7.7 ms (95% CI: 5.1-10.3 ms, P<0.001); and 40 years of age the difference was 3.4 ms (95% CI: 1.5-5.3, P<0.001).
Overall, the QRS c increased in people with Type 1 diabetes, but it did not change with age for either group ( Figure S2 ; age: P=0.5, interaction age-diabetes: P=0.8). The adjusted prediction (Figure 2 ) yielded the same result (age: P=0.7, interaction age-diabetes: P=0.7).
A contrasting pattern was observed for the JT c . Mean JT c did not increase in people with Type 1 DM compared to controls (Table 2) ; however, as seen in Figures 3 and S3 , at a younger age, JT c increased in people with Type 1 diabetes. This relative increase was not present at an older age (interaction age-diabetes: P<0.01). In both groups, JT c was longer at an older age. The adjusted prediction ( Figure 3 
Discussion
In the current study, changes in depolarization and repolarization were studied in 855 people aged 18-86 years with Type 1 diabetes who had normal ejection fraction and no known cardiac disease compared to 1710 age-and sex-matched controls from the general population.
The main findings are that JT c increased relatively in younger people with Type 1 diabetes compared to controls, that QRS c increased in people with Type 1 diabetes of all ages, and similarly, that QT c increased with age for people with and without Type 1 diabetes. Furthermore, it was shown that RHR increased in people with Type 1 diabetes even without known cardiac disease. People with Type 1 DM have an overall increased QT c interval compared to the general population, which is in agreement with previous findings [8, 9, [21] [22] [23] . The QT interval is a composite measure consisting of both the times for depolarization (QRS) and repolarization (JT). In the literature, the QT interval has often been used a synonym for cardiac repolarization [8, 23] since QRS duration is assumed to be constant and small. However, depolarization is affected in people with Type 1 diabetes, and therefore the JT interval is a better measure for repolarization [5] .
The unchanged JT c presented in Table 2 is an average across people of all ages. The current study finds a different JT c relationship with age for people with and without Type 1 diabetes. It was found that JT c increased at a young age (Figure 3) , which is in agreement with the 2001 finding that young people with Type 1 DM have a 6-fold greater risk of QT c prolongation [8] . In support of this, a British study of twins with Type 1 diabetes aged between 10-44 years without ischemic heart disease found increased QT c in the twin with Type 1 DM [9] . At older ages no difference in JT c was found. For this reason, the mean JT c increase over the age range from young person to elderly adult is not significantly different from zero. The QT c -age relationships in both groups are similar to those of the JT c -age relationships.
The Food and Drug Administration (FDA) has set a regulatory threshold of concern for repolarization duration increase of 5 ms [24] , and this has been adopted by the European Medicines Agency [25] . Drugs that increase repolarization duration by more than this threshold are potentially proarrhythmic. In this study, the threshold of concern was exceeded in people with Type 1 diabetes at ages <35 years, but not at ages >35 years (Figure 1 ), which is in agreement with the theory that dead in bed syndrome is caused by ventricular arrhythmias [3] .
It could be speculated that hypertension, smoking, BMI, and kidney disease could affect the ECG and the ECG-age relationship. It is for this reason that predicted differences (Figures 1-3) were based on models adjusted for those factors, although all models gave similar results with or without adjustment. Lower blood pressure and total cholesterol levels in people with Type 1 diabetes might be a consequence of the fact that a team of healthcare professionals monitors them closely, and that care is taken to lower modifiable risk factors such as blood pressure and total cholesterol levels.
The fact that repolarization increased only in young people with Type 1 diabetes is in agreement with the theory that repolarization prolongation is involved in the dead in bed syndrome [3] . In support of this, the QT c interval has previously been linked to increased mortality in people with Type 1 diabetes both as a continuous variable and also for the occurrence of prolonged QTc >440 ms or >450 ms [26, 27] .
Different methods exist to calculate a heart rate-corrected JT interval [5, 19, 28] . The current study used a linear model for correction, which was found to be superior to the simple subtraction method of JT c = QT c -QRS [19] . For the QT interval, the use of Fridericia's non-linear correction method (cubic root correction) yielded similar results as produced by linear correction (data not shown). 
Depolarization
It was found that QRS c was increased in people with Type 1 diabetes. Although no information about heart rate-corrected QRS duration was available from other studies of people with Type 1 diabetes, some data are available for the non-corrected QRS duration. One study found a shortening of the QRS complex in people with Type 1 diabetes (n=22) compared to controls (n=22) [10] . The participants were mainly very young adults who had no known cardiovascular complications and took no medication except for insulin. Therefore, QRS shortening may well be a feature of elevated heart rate and not of Type 1 diabetes, since the QRS duration physiologically shortens with increasing heart rate [18] . However, in a study of children and adolescents with Type 1 diabetes (n=40), the QRS duration increased compared to controls (n=20) [29] .
Heart rate
In the current study, people with Type 1 diabetes had an increased RHR of~10 bpm. A higher RHR of similar magnitude has been reported in smaller studies of Type 1 diabetes [9, 10, 21] , and this finding has now therefore been confirmed in a larger population. An elevated RHR was found to be related to mortality and cardiovascular outcomes in several studies including the general population [30, 31] and people with Type 2 diabetes [27] although, surprisingly, one study did not find RHR predicted mortality for people with Type 1 DM [27] . The higher RHR may be caused by a decrease in parasympathetic tone due to autonomic neuropathy [32] . The relative increase in sympathetic tone has previously been hypothesized as a cause of nocturnal death in young people with Type 1 diabetes (i.e. people who suffer from the dead in bed syndrome) [33] . However, other factors such as ventricular remodelling with a decrease in stroke volume may also play a role [12] . It is notable that an increased RHR of 10 bpm is present in people with Type 1 diabetes even without known heart disease, which suggests that diabetic cardiac autonomic neuropathy precedes cardiovascular complications and is therefore not a consequence of it.
Limitations
A wide range of ages was used in this study, but findings should not be extrapolated beyond this range. Most participants were Caucasians, and findings cannot be extrapolated to non-Caucasian populations. It is a limitation to the study that HbA 1c measurements were not necessarily obtained on the same day of the study for all participants, and also that Cardiac Autonomic Neuropathy was not assessed.
In conclusion, repolarization is impaired in younger people with Type 1 diabetes relative to controls, whereas depolarization is impaired across all ages in people with Type 1 diabetes. Heart rate is increased by 10 bpm in people with Type 1 diabetes. These changes can be observed before clinical cardiac symptoms occur.
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Additional Supporting Information may be found in the online version of this article: Table S1 . Heart rate correction using a linear model. Results from linear regression. Figure S1 . QT interval in Type 1 diabetes vs. control. Figure S2 . QRS interval in Type 1 diabetes vs. control. Figure S3 . JT interval in Type 1 diabetes vs. control. Figure S4 . Heart rate vs. glycated haemoglobin in Type 1 diabetes vs. control.
